Results 31 to 40 of about 3,416 (115)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

open access: yes, 2021
We report the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after receiving the coronavirus disease 2019 (COVID-19) vaccine BNT162b (Pfizer–BioNTech).
Saki Okuda   +2 more
core   +1 more source

Propylthiouracil-induced vasculitis with alveolar hemorrhage after 31 years of treatment: a case report

open access: yesClinical Diabetes and Endocrinology
Background Propylthiouracil is an antithyroid medication that is associated with ANCA positivity, often in the absence of clinically overt vasculitis. Propylthiouracil-induced ANCA-associated vasculitis (AAV) is characterized by multiple antigenicity and
Ro’a Khalaf   +4 more
doaj   +1 more source

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for methimazole and propylthiouracil.

open access: yesPLoS ONE
BackgroundMethimazole and propylthiouracil are the most common antithyroid drugs. We assessed the safety signals associated with methimazole and propylthiouracil by data mining the FDA pharmacovigilance database.MethodsData were retrieved from the FAERS ...
Yun Li, Hang Li, Qiong Sun, Qin Long
doaj   +1 more source

Pseudotumor Cerebri After L-Thyroxine Therapy

open access: yesPediatric Neurology Briefs, 1997
Pseudotumor cerebri in an infant treated with L-thyroxine for transient neonatal hypothyroidism is reported from the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
J Gordon Millichap
doaj   +1 more source

Intersection of systemic lupus erythematosus and autoimmune thyroid disease: Shared pathophysiology, epidemiology, diagnosis, and management

open access: yesRheumatology &Autoimmunity, EarlyView.
A proposed mechanistic framework of systemic lupus erythematosus (SLE) and autoimmune thyroid disease (AITD) pathogenesis. In Stage 1, genetically susceptible individuals harbor risk variants within major histocompatibility complex (HLA) and non‐HLA loci that impair central and peripheral immune tolerance mechanisms within the thymic and peripheral ...
Elisa Elisa   +3 more
wiley   +1 more source

Teratogenic effects of Propylthiouracil on Swiss albino mice fetuses – A gross study

open access: yesAsian Journal of Medical Sciences, 2022
Background: Propylthiouracil is an antithyroid drug used to treat hyperthyroidism in pregnancy, as euthyroid state is necessary for optimal pregnancy outcome.
Samta Tiwari   +2 more
doaj   +1 more source

Long‐Term Determinants of Lean Mass in Ageing Adults: A 17‐Year Longitudinal Cohort Study With Repeated Measures

open access: yesAustralasian Journal on Ageing, Volume 45, Issue 4, December 2026.
ABSTRACT Objective Age‐related loss of lean mass is a hallmark of sarcopenia and a contributor to functional decline and morbidity in ageing populations. This study aimed to identify long‐term determinants of lean mass during ageing. Methods Data from 3033 participants (ages 20–96 years; 49% women) in the Geelong Osteoporosis Study were analysed using ...
Aminu Suleiman   +6 more
wiley   +1 more source

Model of induction of thyroid dysfunctions in adult female mice Modelo de indução de disfunções tireoidianas em camundongos fêmeas adultas

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2007
It is described the elaboration of a protocol to induce hyperthyroidism and hypothyroidism in mice by administrating thyroxin and propylthiouracil, respectively, in the drinking water.
E. Ferreira   +4 more
doaj   +1 more source

Seronegative Propylthiouracil‐Induced Reversible Bilateral Sensory Neural Hearing Loss Without Systemic Vasculitis: A Case Report and Review of Literature

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Propylthiouracil (PTU) is a thioamide drug used in the management of hyperthyroidism in selected clinical settings. While PTU is associated with well‐known adverse effects such as hepatotoxicity, agranulocytosis, and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis, ototoxicity is an exceptionally rare complication.
Adane Alemayehu Abera   +5 more
wiley   +1 more source

Propylthiouracil and peripheral neuropathy [PDF]

open access: yes, 1992
Peripheral neuropathy is a rare manifestation in hyperthyroidism. We describe the neurological manifestations of a 38 year old female with Graves' disease who developed peripheral neuropathy in the course of her treatment with propylthiouracil. After the
João G. Corrêa Meyer Neto   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy